Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.24M Sell
76,852
-618
-0.8% -$71.3K 0.19% 126
2025
Q4
$8.15M Buy
77,470
+142
+0.2% +$13.3K 0.17% 136
2025
Q3
$6.49M Buy
77,328
+13,593
+21% +$1.12M 0.15% 156
2025
Q2
$5.05M Buy
63,735
+3,300
+5% +$262K 0.16% 134
2025
Q1
$5.42M Sell
60,435
-5,588
-8% -$522K 0.21% 110
2024
Q4
$6.57M Sell
66,023
-23,154
-26% -$2.39M 0.25% 95
2024
Q3
$10.1M Buy
89,177
+12,011
+16% +$1.43M 0.44% 45
2024
Q2
$9.55M Buy
77,166
+15,700
+26% +$2.02M 0.45% 45
2024
Q1
$8.11M Sell
61,466
-3,685
-6% -$454K 0.42% 53
2023
Q4
$7.1M Buy
65,151
+3,853
+6% +$400K 0.41% 56
2023
Q3
$6.31M Buy
61,298
+752
+1% +$81.1K 0.49% 47
2023
Q2
$6.99M Sell
60,546
-23,648
-28% -$2.69M 0.64% 23
2023
Q1
$8.96M Buy
84,194
+33,334
+66% +$3.6M 0.57% 31
2022
Q4
$5.64M Buy
50,860
+7,983
+19% +$816K 0.56% 33
2022
Q3
$3.91K Buy
42,877
+3,954
+10% +$353K 0.15% 90
2022
Q2
$3.55M Sell
38,923
-21,414
-35% -$1.9M 0.49% 36
2022
Q1
$4.95M Buy
60,337
+2,460
+4% +$194K 0.53% 32
2021
Q4
$4.44M Buy
57,877
+10,893
+23% +$868K 0.46% 43
2021
Q3
$4.14M Buy
46,984
+12,765
+37% +$971K 0.52% 37
2021
Q2
$2.66M Buy
34,219
+6,919
+25% +$515K 0.37% 59
2021
Q1
$2.01M Buy
27,300
+4,992
+22% +$368K 0.34% 70
2020
Q4
$1.74M Sell
22,308
-447
-2% -$34.2K 0.36% 64
2020
Q3
$1.8M Sell
22,755
-1,387
-6% -$109K 0.43% 57
2020
Q2
$1.78M Sell
24,142
-1,105
-4% -$83.2K 0.46% 48
2020
Q1
$1.85M Sell
25,247
-944
-4% -$74.2K 0.63% 35
2019
Q4
$2.27M Sell
26,191
-1,904
-7% -$156K 0.59% 36
2019
Q3
$2.26M Buy
28,095
+1,715
+7% +$137K 0.65% 33
2019
Q2
$2.11M Sell
26,380
-732
-3% -$56K 0.68% 30
2019
Q1
$2.15M Buy
27,112
+8,245
+44% +$617K 0.7% 26
2018
Q4
$1.38M Sell
18,867
-1,280
-6% -$90.4K 0.59% 24
2018
Q3
$1.36M Buy
+20,147
New +$1.28M 0.64% 28
2018
Q1
$1.02M Buy
19,685
+1,699
+9% +$91.8K 0.47% 32
2017
Q4
$966K Buy
+17,986
New +$997K 0.45% 49

Other funds holding MRK

MGO One Seven's MRK Position: Q1 2026 in Review

MGO One Seven reduced its Merck (MRK) stake by 0.8% in Q1 2026, selling an estimated $71.3K and leaving 76,852 shares worth $9.24M. The position accounts for 0.19% of the portfolio, ranked #126.

MGO One Seven first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. The position peaked at $10.1M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • MGO One Seven held 76,852 shares of Merck worth $9.24M as of Q1 2026.
  • MGO One Seven sold 618 Merck shares in Q1 2026, an estimated $71.3K.
  • Merck made up 0.19% of MGO One Seven's portfolio in Q1 2026, its #126 holding.
  • MGO One Seven first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
  • MGO One Seven's Merck position peaked at $10.1M in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.